Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study

Autor: Ragon, Brittany Knick, Odenike, Olatoyosi, Baer, Maria R., Stock, Wendy, Borthakur, Gautam, Patel, Keyur, Han, Lina, Chen, Helen, Ma, Helen, Joseph, Loren, Zhao, Yang, Baggerly, Keith, Konopleva, Marina, Jain, Nitin
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia July 2019 19(7):431-440
Databáze: ScienceDirect
Externí odkaz: